Emerging treatments for postmenopausal osteoporosis – focus on denosumab
Piet GeusensDepartment of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands and Biomedical Research Institute, University Hasselt, BelgiumAbstract: The pathway of the receptor activator of the nuclear factor κB ligand (RANKL),...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://doaj.org/article/4cf8c096344043bb8ebe89a9ae1dbba8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|